← All organizations

Miami Cancer Institute

Academic/HospitalWebsite ↗

Also known as: Miami Cancer Institute | University of Pisa / Miami Cancer Institute

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 31, 2024

Timeline

2010s

Jan 26, 2017
Miami Cancer Institute— Founded

Drugs by trial phase (13 distinct, 8 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (9 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

t-cell depleted lymphocytes

Other trials (1 own, 0 via acquisition)

pegph20

Indications

Studied for

Recent trials (8)

NCT06329830OfficialPhase 1/Phase 2Oct 31, 2024
NCT05789589CollaboratorPhase 1/Phase 2Aug 16, 2023
NCT05425004Overall official - principal investigatorPhase 2May 27, 2022
NCT05350163Overall official - principal investigatorPhase 1Apr 5, 2022
NCT03778957Overall official - principal investigatorPhase 3Nov 30, 2018
NCT03274661CollaboratorPhase 2Nov 2, 2017
NCT02921022CollaboratorN/AOct 1, 2016
NCT02525653CollaboratorPhase 2Aug 1, 2015

Details

Founded: Miami, FL, US Jan 26, 2017
Last known activity: Oct 31, 2024